Paul Jones is the CEO of Vortex Group, one of the leading companies in the NetScientific (NSCI) portfolio. He is looking to build the Vortex platform focused on capturing Circulating Tumour Cells (CTCs) into an industry leading solution in the liquid biopsy space. He also plays a key role as Venture Partner exploring the potential for companies across the NSCI portfolio to deliver to an affordable population health agenda. Previously, Paul worked at Illumina, Inc., where he was the Global Head of Population Genomics. He led the team that created, developed and actively managed large-scale programmes across more than 50 different countries. Prior to this, Paul was the founding CEO of Genomics Enterprises, the arm of Genomics England responsible for all commercial aspects of the 100,000 Genomes Project. Paul has also held roles as Director and Leader of Global Life Sciences at Cisco and Head of Global eMarketing & eSales at Novartis. Early in his career he was a Management Consultant at PwC, focused on life sciences. Paul completed a Certificate in Private Equity at Imperial College, London in 2022, an MBA from the University of Sheffield, in 1992, and an undergraduate degree majoring in physiology in 1989.